Fertin, officially known as Fertin Pharma A/S, is a leading player in the chemicals nec industry, headquartered in Denmark (DK). Founded in 2006, the company has established itself as a pioneer in the development and manufacturing of innovative pharmaceutical and consumer health products, particularly in the realm of oral delivery systems.
With a strong operational presence across Europe and North America, Fertin is renowned for its unique expertise in gum-based delivery technologies, which enhance the efficacy of active ingredients. The company has achieved significant milestones, including partnerships with major global brands, solidifying its market position as a trusted provider of high-quality solutions. Fertin's commitment to research and development continues to drive its success, making it a notable name in the chemicals sector.
+27 vs industry average
Fertin’s score of 57 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Fertin?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Chemicals is among the most carbon-intensive industries
Industry performance
The Chemicals industry has reduced its overall emissions by 19% since 2018
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Fertin's reported carbon emissions
Fertin, a chemicals nec company headquartered in DK, is committed to climate action. In 2024, the company reported total global emissions of approximately 41.5 million kg CO2e. This figure comprises approximately 3.7 million kg CO2e for Scope 1, approximately 4.1 million kg CO2e for Scope 2 (location-based), and approximately 36.7 million kg CO2e for Scope 3.
For the year 2023, Fertin reported total global emissions of approximately 41.2 million kg CO2e. This includes approximately 4.7 million kg CO2e for Scope 1, approximately 4.7 million kg CO2e for Scope 2 (location-based), and approximately 34.3 million kg CO2e for Scope 3.
In 2022, Fertin disclosed Scope 1 and 2 market-based emissions of approximately 3.7 million kg CO2e. Similarly, in 2021, Scope 1 and 2 market-based emissions were approximately 3.6 million kg CO2e.
Fertin's emissions data for Scope 3, specifically for purchased goods and services, is noted as missing. The company's climate commitments and emissions reporting are cascaded from its parent organisation, Philip Morris International Inc., at cascade level 2, as a current subsidiary. Fertin Pharma A/S is identified as the source organisation for performance data.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Fertin’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Fertin yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Philip Morris International Inc.
Carbon Disclosure Project
Inherited from Philip Morris International Inc.
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Fertin
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project